Up to 70% of Peripheral IV Cannula/Catheter (PIVC) procedures fail at first attempt resulting in patient harm, delayed treatments and wasted clinical time and resources.
Problem
Cannulight – a novel, sterile, disposable device that helps clinicians, nurses and paramedics give confident, precise intra venous access...every time.
The Solution
What is Cannulight?
The Cannulight device is a small, lightweight, sterile, disposable device that attaches to existing marketed PIVCs. When the IV catheter is inserted it illuminates green when it hits the chosen vein. If the IV catheter is advanced too far and exits the vein, it turns off. The clinician can reposition the catheter back inside the vein, and the device illuminates green again.
This differs from the existing practice of sighting blood in the 'Flashback' chamber of the catheter which only indicates first vein entry - not exit, re-entry nor correct positioning. This often results in a 'false-positive' which can contribute to a failed PIVC insertion and subsequent injury to patients. Using its patent-protected technology, Cannulight gives the user a real-time, accurate, binary signal of success, that results in confident and precise PIVC insertion, every time.
Cannulight Technology Limited is a New Zealand based medical device company (with USA, UK, and Australian subsidiaries), founded by the inventor of the Cannulight device, Dr James Stone. The device was created to help clinicians with the difficult task of Peripheral IntraVenous Catheter (PIVC) insertions, which can have a failure rate of between 35-75%. PIVC insertion failure can cause profound health problems to patients, significant stress to clinicians, and negative financial consequences to healthcare organizations. Dr Stone encountered these problems first-hand, when performing intravenous sedation at his dental clinic. After extensive searching, Dr Stone was unable to find a cost efficient device, that didn’t require specialist skills or training.
Our story
Recent Wins
The team
Dr James Stone
Inventor, Founder and CEO of Cannulight Technology Limited
Dr James Stone is a dental surgeon, company director of The Tooth Company Limited, and CEO of Cannulight Technology Limited, both based in Auckland, New Zealand. Following years of treating anxious patients under intra-venous sedation, James identified the need for novel technology to assist in the placement of intravenous catheters. He founded Cannulight Technology Limited in 2022 and was the first human to trial the device. James is a successful clinician, business owner and leader.
Mike Munley
COO of Cannulight Technology Limited
Mike is a senior global healthcare business executive with depth of Medical Technology, Pharmaceutical and Over the Counter Medicines experience across many markets. His experience was gained in US and Anglo-American multinational corporations, US and UK start-up and scale-up healthcare companies as well as his successful consultancy business. With a proven record of strategic thinking combined with action-oriented pragmatism Mike has led major innovations and initiatives that have built global leadership in healthcare categories. His experience is complimented by an extensive international network of experts and colleagues. Mike worked for Cannulight Technology as medtech advisor prior to becoming Chief Operating Officer.
